Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mottiwala Aziz
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Wahl Bryan
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Azamian Bobak R.
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Whitfield Dianne C.
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Neervannan Seshadri
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Azamian Bobak R.
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Wahl Bryan
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mottiwala Aziz
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Neervannan Seshadri
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Farrow Jeffrey S
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Whitfield Dianne C.
Tarsus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(6.7%),TANG CAPITAL MANAGEMENT, LLC(6.7%), etc.
Tarsus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(6.71%),Bihua Chen(6.71%), etc.
Tarsus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(9.5%),Roderick Wong, M.D.(9.5%)
Tarsus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Vivo Capital IX, LLC(2.7%),Vivo Capital Fund IX, L.P.(2.7%)
Tarsus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Morgan Stanley(5.9%)
Tarsus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cowen Financial Products LLC(5.77%)
Tarsus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TimesSquare Capital Management, LLC(0%)
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lin Elizabeth Yeu
Tarsus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.6%)
No Data